XML 54 R36.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investments in Equity Securities (Tables)
12 Months Ended
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Investment
The carrying amount of our current and former investments consisted of the following at December 31:
(in millions)20232022
ABI
$9,676 $8,975 
Cronos335 375 
JUUL
 250 
Total
$10,011 $9,600 
(Income) losses from our current and former investments in equity securities consisted of the following:
For the Years Ended December 31,
(in millions)202320222021
ABI (1)
$(539)$1,973 $5,564 
Cronos (1)
46 213 415 
(Income) losses from investments under equity method of accounting(493)2,186 5,979 
JUUL250 
(2)
1,455 
(3)
— 
(Income) losses from investments in equity securities$(243)$3,641 $5,979 
(1) Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investments required under the equity method of accounting.
(2) Represents loss as a result of the disposition of our JUUL equity securities discussed below.
(3) Represents the estimated change in fair value. Prior to the disposition of our JUUL equity securities on March 3, 2023, we accounted for our former investment in JUUL as an investment in an equity security measured at fair value.
Investees’ summarized financial data for our equity method investments was as follows:
For Altria’s Year Ended December 31,
2023 (1)
2022 (1)
2021 (1)
(in millions)ABIOther InvestmentsABIOther InvestmentsABIOther Investments
Net revenues$59,841 $87 $57,267 $947 $52,864 $1,313 
Gross profit$32,371 $9 $31,588 $525 $30,653 $757 
Earnings (losses) from continuing operations$7,956 $(105)$7,879 $(521)$7,434 $(800)
Net earnings (losses)$7,956 $(108)$7,879 $(521)$7,434 $(800)
Net earnings (losses) attributable to equity investments$6,284 $(108)$5,838 $(520)$5,780 $(798)
At September 30,
2023 (1)
2022 (1)
(in millions)ABIOther InvestmentsABIOther Investments
Current assets$22,835 $918 $24,164 $963 
Long-term assets$188,003 $232 $182,087 $274 
Current liabilities$35,407 $31 $32,649 $38 
Long-term liabilities$91,791 $3 $96,497 $
Noncontrolling interests
$11,231 $(3)$11,778 $(3)
(1) Reflects a one-quarter lag. Other Investments reflect summarized financial data of Cronos, as well as JUUL’s financial data for the periods during which we accounted for our former investment in JUUL as an equity method investment under the fair value option.
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation
The following table provides a reconciliation of the beginning and ending balance of our former investment in JUUL, which was classified in Level 3 of the fair value hierarchy prior to the disposition of our JUUL equity securities:
(in millions)Investment Balance
Balance at December 31, 2021$1,705 
Unrealized gains (losses) included in (income) losses from investments in equity securities(1,455)
Balance at December 31, 2022250 
Non-cash, pre-tax (loss) on disposition included in (income) losses from investments in equity securities(250)
Balance at December 31, 2023$